Hypoglycemia causes: Difference between revisions

Jump to navigation Jump to search
Medhat (talk | contribs)
No edit summary
Medhat (talk | contribs)
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hypoglycemia}}
{{Hypoglycemia}}
{{CMG}} {{CLG}}
{{CMG}} {{CLG}} {{MAD}}


==== Overview ====
==== Overview ====
Line 29: Line 29:
* Maternal hyperglycemia due to [[diabetes]] or iatrogenic glucose administration
* Maternal hyperglycemia due to [[diabetes]] or iatrogenic glucose administration
* [[Sepsis]]
* [[Sepsis]]
* Congenital hypopituitarism: cortisol and growth hormone regulate glucose level.
* Congenital hypopituitarism: cortisol and growth hormone regulate glucose level.
* Maternal treatment with beta-sympathomimetic agents (eg, terbutaline and beta-blockers), which interrupts glycogenolysis by blocking epinephrine's effect [12]
* Maternal treatment with beta-sympathomimetic agents (eg, terbutaline and beta-blockers), which interrupts glycogenolysis by blocking epinephrine's effect [12]
* Hypothermic infants who have diminished availability of glucose and increased rates of glucose utilization
* Hypothermic infants who have diminished availability of glucose and increased rates of glucose utilization
* Severe hepatic dysfunction due to impairment of both glycogenolysis and gluconeogenesis
* Severe hepatic dysfunction due to impairment of both glycogenolysis and gluconeogenesis
*[[Congenital hyperinsulinism]]:
*[[Congenital hyperinsulinism]]:
 
**Infant of a diabetic mother is the most common cause of hypoglycemia due to hyperinsulinism. Prolonged intrapartum hyperglycemia in fetus leads to hypertrophied and hyperfunctioning beta cells causing hyperinsulinsim. It is transient and resolves two to four days after birth.  
* Infant of a diabetic mother is the most common cause of hypoglycemia due to hyperinsulinism. Prolonged intrapartum hyperglycemia in fetus leads to hypertrophied and hyperfunctioning beta cells causing hyperinsulinsim. It is transient and resolves two to four days after birth.  
**[[Beckwith-Wiedemann syndrome]]
 
**[[Persistent hyperinsulinemic hypoglycemia of infancy]]: mutations in genes encoding enzymes that control intracellular metabolic pathways of the pancreatic beta cell. The genes most often affected control the sulfonylurea receptor that control the functional ATP-dependent potassium channel in the beta cell membrane.
* [[Beckwith-Wiedemann syndrome]]
**Excess exogenous insulin given to newborns with hyperglycemia may result in hypoglycemia 16
 
**Neonatal conditions associated with excess insulin secretion include alloimmune hemolytic disease of the newborn, heart failure and sepsis. These conditons increase anaerobic glycolysis due to decreased tissue perfusion.[17]
* [[Persistent hyperinsulinemic hypoglycemia of infancy]]: mutations in genes encoding enzymes that control intracellular metabolic pathways of the pancreatic beta cell. The genes most often affected control the sulfonylurea receptor that control the functional ATP-dependent potassium channel in the beta cell membrane.
**polycythemia may result from greater glucose utilization by the increased mass of red blood cells.  
* Excess exogenous insulin given to newborns with hyperglycemia may result in hypoglycemia 16
*[[Inborn error of metabolism|Inborn errors of carbohydrate metabolism]]:
* Neonatal conditions associated with excess insulin secretion include alloimmune hemolytic disease of the newborn, heart failure and sepsis. These conditons increase anaerobic glycolysis due to decreased tissue perfusion.[17]
**Disorders of gluconeogenesis: fructose-1,6-bisphosphatase deficiency, pyruvate carboxylase deficiency.
* polycythemia may result from greater glucose utilization by the increased mass of red blood cells.  
**Disorders of carbohydrate metabolism: hereditary fructose intolerance, galactosemia.
[[Inborn error of metabolism|Inborn errors of carbohydrate metabolism]]:
**Disorders of fatty acid metabolism: medium or long-chain acyl-CoA dehydrogenase deficiency). 11
* Disorders of gluconeogenesis: fructose-1,6-bisphosphatase deficiency, pyruvate carboxylase deficiency.
* Disorders of carbohydrate metabolism: hereditary fructose intolerance, galactosemia.
 
*Disorders of fatty acid metabolism: medium or long-chain acyl-CoA dehydrogenase deficiency). 11


====Hypoglycemia in Young Children====
====Hypoglycemia in Young Children====

Revision as of 16:32, 17 July 2017

Hypoglycemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoglycemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoglycemia causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoglycemia causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoglycemia causes

CDC on Hypoglycemia causes

Hypoglycemia causes in the news

Blogs on Hypoglycemia causes

Directions to Hospitals Treating Hypoglycemia

Risk calculators and risk factors for Hypoglycemia causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Carlos A Lopez, M.D. [2] Mohammed Abdelwahed M.D[3]

Overview

Is when blood sugar decreases to below normal levels. This may result in a variety of symptoms including clumsiness, trouble talking, confusion, loss of consciousness, seizures, or death. Some causes of hypoglycemia are chloramphenicol, addison's disease, acute fatty liver of pregnancy and sepsis.

Causes

Life Threatening Causes
Common Causes

Causes

Hypoglycemia in Newborn Infants

Hypoglycemia is a common problem in critically ill or extremely low birthweight infants. If not due to maternal hyperglycemia, in most cases it is multifactorial, transient and easily supported. In a minority of cases hypoglycemia turns out to be due to significant hyperinsulinism, hypopituitarism or an inborn error of metabolism and presents more of a management challenge.

  • Transient neonatal hypoglycemia: With loss of the continuous transplacental supply of glucose, plasma glucose concentration in the healthy term newborn falls during the first two hours after delivery[1,2,6,7]. plasma glucose concentration is maintained by glycogenolysis during the first 8 to 12 hours then by gluconeogenesis.[8,9]
  • Prematurity, intrauterine growth retardation and perinatal asphyxia.
  • Maternal hyperglycemia due to diabetes or iatrogenic glucose administration
  • Sepsis
  • Congenital hypopituitarism: cortisol and growth hormone regulate glucose level.
  • Maternal treatment with beta-sympathomimetic agents (eg, terbutaline and beta-blockers), which interrupts glycogenolysis by blocking epinephrine's effect [12]
  • Hypothermic infants who have diminished availability of glucose and increased rates of glucose utilization
  • Severe hepatic dysfunction due to impairment of both glycogenolysis and gluconeogenesis
  • Congenital hyperinsulinism:
    • Infant of a diabetic mother is the most common cause of hypoglycemia due to hyperinsulinism. Prolonged intrapartum hyperglycemia in fetus leads to hypertrophied and hyperfunctioning beta cells causing hyperinsulinsim. It is transient and resolves two to four days after birth.
    • Beckwith-Wiedemann syndrome
    • Persistent hyperinsulinemic hypoglycemia of infancy: mutations in genes encoding enzymes that control intracellular metabolic pathways of the pancreatic beta cell. The genes most often affected control the sulfonylurea receptor that control the functional ATP-dependent potassium channel in the beta cell membrane.
    • Excess exogenous insulin given to newborns with hyperglycemia may result in hypoglycemia 16
    • Neonatal conditions associated with excess insulin secretion include alloimmune hemolytic disease of the newborn, heart failure and sepsis. These conditons increase anaerobic glycolysis due to decreased tissue perfusion.[17]
    • polycythemia may result from greater glucose utilization by the increased mass of red blood cells.
  • Inborn errors of carbohydrate metabolism:
    • Disorders of gluconeogenesis: fructose-1,6-bisphosphatase deficiency, pyruvate carboxylase deficiency.
    • Disorders of carbohydrate metabolism: hereditary fructose intolerance, galactosemia.
    • Disorders of fatty acid metabolism: medium or long-chain acyl-CoA dehydrogenase deficiency). 11

Hypoglycemia in Young Children

Single episodes of hypoglycemia due to gastroenteritis or fasting, but recurrent episodes nearly always indicate either an inborn error of metabolism, congenital hypopituitarism, or congenital hyperinsulinism

Hypoglycemia in Older Children and Young Adults

By far the most common cause of severe hypoglycemia in this age range is insulin injected for type 1 diabetes. Circumstances should provide clues fairly quickly for the new diseases causing severe hypoglycemia. All of the congenital metabolic defects, congenital forms of hyperinsulinism, and congenital hypopituitarism are likely to have already been diagnosed or are unlikely to start causing new hypoglycemia at this age. Body mass is large enough to make starvation hypoglycemia and idiopathic ketotic hypoglycemia quite uncommon. Recurrent mild hypoglycemia may fit a reactive hypoglycemia pattern, but this is also the peak age for idiopathic postprandial syndrome, and recurrent "spells" in this age group can be traced to orthostatic hypotension or hyperventilation as often as demonstrable hypoglycemia.

Hypoglycemia in Older Adults

The incidence of hypoglycemia due to complex drug interactions, especially involving oral hypoglycemic agents and insulin for diabetes rises with age. Though much rarer, the incidence of insulin-producing tumors also rises with advancing age. Most tumors causing hypoglycemia by mechanisms other than insulin excess occur in adults

  • Drugs: they are the most common cause of hypoglycemia.[1]
  • Insulin or insulin secretagogue: sulfonylureas, glyburide and less common glipizide or glimepiride due to longer duration of action. [30]. They suppress hepatic glucose production and stimulate glucose utilization causing hypoglycemia.
  • Other drugs in non-diabetic patients: quinolones, pentamidine, quinine, beta blockers, angiotensin-converting enzyme inhibitors, and IGF-1 especially in in older patients with underlying renal or hepatic dysfunctions. [32]
  • Alcohol: due to hepatic glycogen depletion in fasting patients. Alcohol can induce hypoglycemia alone or associated with other hypoglycemic drugs.
  • Critical illnesses: hepatic, renal, or cardiac failure, sepsis. [34] It occurs due to impaired liver gluconeogenesis. Sepsis induced cytokines secretion cause supression of gluconeogenesis. 36
  • Hormone deficiency: cortisol in acquired adrenal insufficiency or acquired hypopituitarism
  • Nonislet cell tumor: Hypoglycemia usually occurs as a result of tumor production of IGF-2. 1
  • Insulinoma
  • Reactive hypoglycemia: there are different kinds of reactive hypoglycemia:[1] Alimentary Hypoglycemia (consequence of dumping syndrome; it occurs in about 15% of people who have had stomach surgery) Helicobacter pylori-induced gastritis. Congenital enzyme deficiencies (hereditary fructose intolerance, galactosemia, and leucine sensitivity of childhood). Idiopathic reactive hypoglycemia Late Hypoglycemia (Occult Diabetes; characterized by a delay in early insulin release from pancreatic B cells, resulting in initial exaggeration of hyperglycemia during a glucose tolerance test).
  • Post gastric bypass hypoglycemia: rapid jejunal emptying with exaggerated insulin response.
  • Insulin autoimmune hypoglycemia: it occurs in patients who have antibodies directed to endogenous insulin or to the insulin receptor. 41
  • Accidental, surreptitious, or malicious hypoglycemia

References


Template:WikiDoc Sources